Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Percutaneous Excision Trial (I-Pet): A Multi-Center Clinical Study Of The Intact Breast Lesion Excision System (Bles) To Demonstrate That A Definitive Diagnosis Can Be Made From The Tissue Sample Collected With The Intact Bles.

NCT00720642 is registered in ClinicalTrials.gov with Intact Medical Corporation as lead sponsor.

NCT NCT00720642
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00720642 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Percutaneous Excision Trial (I-Pet): A Multi-Center Clinical Study Of The Intact Breast Lesion Excision System (Bles) To Demonstrate That A Definitive Diagnosis Can Be Made From The Tissue Sample Collected With The Intact Bles.
Lead sponsor
Intact Medical Corporation
Phase
Observational
Overall status
Completed
Start date
July 31, 2006
Completion date
June 30, 2011
Enrollment
1,170 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

imaged breast abnormalities